2024-08-15T00:20:38-05:00 2023-09-30 346565596 Ernst & Young LLP 1 Manhattan West New York NY 10001 990 2022-10-01 043554536 Dana-Farber Children's Hospital Cancer Care Inc DANA 8887334662 450 Brookline Avenue BP418 Boston MA 02215 Doug Vanderslice Treasurer 6173556000 2024-08-08 1 1 Nicole Sokolowski P01683199 2127333000 2022 2024-08-08 14:25:15Z Dana-FarberBoston Children's Cancer and Blood and Disorders Center Scott Armstrong MD 450 Brookline Avenue BP418 Boston MA 02215 0 0 X https://www.danafarberbostonchildrens.org/ X 2000 MA To oversee, coordinate and support the Pediatric Oncology Programs at Boston Children's Hospital and Dana-Farber Cancer Institute, Inc. 8 6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 29390 0 0 0 0 224794 296404 254184 296404 -254184 -296404 0 0 0 0 0 0 X To oversee, coordinate and support the Pediatric Oncology Programs at Boston Children's Hospital and Dana-Farber Cancer Institute, Inc. 0 0 296404 0 0 Dana-Farber/Children's Hospital Cancer Care, Inc. ("DF/CHCC") is a Massachusetts charitable corporation organized on December 14, 2000, whose members are The Children's Hospital Corporation ("Children's") and Dana-Farber Cancer Institute, Inc. ("Dana-Farber"). Its primary purpose is to oversee, coordinate and support the Pediatric Oncology Program (the "Joint Program"). It also, formalizes the pediatric oncology partnership that has existed between Dana-Farber and Children's since 1947.The Joint Program, which is the largest pediatric oncology program in New England and one of the most active in the country, offers the combined expertise of both a world-class cancer center and an internationally renowned children's hospital. Neighboring institutes connected by pedestrian bridges, Dana-Farber Cancer Institute and Boston Children's Hospital work together to offer seamless, integrated care for children with all types of cancer and blood disorders including the rarest and most complex cases. Through our joint partnership, Dana-Farber/Boston Children's offers more specialists, more treatment options, and more clinical trials than almost any other pediatric center treating cancer and blood disorders in the world.Our Expertise in Treating Pediatric Cancer and Blood Disorders: Our hematologists and oncologists are among the world leaders in their respective specialties; many have pioneered treatments that have been adopted by medical communities around the globe. Our doctors also collaborate with teams of expert subspecialists to provide truly comprehensive care for our patients. Innovative Approaches:Our history of research and innovation has resulted in many of the diagnostic and therapeutic techniques currently used around the world to treat cancer and blood disorders. Today, we continue to stand among the world's leaders in many innovative approaches.Our research, clinical trials, and state-of-the art treatment facilities allow our care teams to provide the safest and most effective care possible.Some of our innovative approaches include:- The Advancing Childhood Cancer Therapies (ACCT) Clinic offers clinical trials for relapsed and refractory cancer. CAR T-cell therapy is a promising new treatment for some of the most challenging cases we face in pediatric leukemia and lymphoma. - Gene therapy delivers DNA into a patient's cells to replace faulty or missing genes or to add new genes in an attempt to cure a disease or make changes so the body is better able to fight off disease. - Immunotherapy is the treatment of disease by inducing, enhancing, or suppressing an immune response. Cancer immunotherapy attempts to stimulate the immune system to reject or destroy tumors.- MIBG therapy is a special treatment for children with refractory or relapsed neuroblastoma. We are one of only a handful of centers in the United States equipped for this type of treatment. - Our Pediatric Cancer Genetic Risk Program provides cancer risk assessment and comprehensive recommendations for managing cancer risk. We also conduct research into many aspects of cancer risk and its management.- Precision medicine allows doctors to tailor treatment to the specific genetic characteristics of a patient's cancer. Dana-Farber/Boston Children's is involved in one of the country's most comprehensive precision cancer medicine initiatives.Conditions we treat: Utilizing proven treatment protocols and innovative therapies, Dana-Farber/Boston Children's Cancer and Blood Disorders Center treats over 100 forms of cancer and blood disorders in children and young adults, including:- Blood Disorders - Our Blood Disorders Center provides comprehensive care for a wide range of non-malignant blood disorders including anemia, hemophilia, myelodysplastic syndrome, sickle cell disease and thalassemia. - Brain Tumors - The specialists in our Brain Tumor Center have the expertise to treat a wide range of malignant brain tumors, including atypical teratoid rhabdoid tumor (AT/RT), diffuse pontine glioma and germ cell tumors of the brain.- Leukemia, Lymphoma, and Histiocytosis - The specialists in our Hematologic Malignancies Center are world leaders in the treatment of pediatric leukemia and lymphoma as well as the primary types of histiocytosis.- Solid Tumors - Our Solid Tumor Center provides advanced treatment, including surgery, for a wide range of solid tumors, including bone tumors like osteosarcoma, soft tissue tumors, neuroblastoma, kidney tumors and liver tumors. - Other Conditions We Treat - The specialists at Dana-Farber/Boston Children's also participate in the care of children and teens with a variety of conditions that do not come under the umbrella of cancers or blood disorders. These other conditions include genetic immunodeficiencies, metabolic disorders, vascular anomalies, and cardiovascular diseases such as pulmonary hypertension and pulmonary vein stenosis. 296404 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 8 6 0 0 0 0 1 1 1 1 1 0 0 0 0 0 0 0 0 0 MA X Doug Vanderslice - Treasurer 6173556000 300 Longwood Avenue Boston MA 02115 X Kevin Churchwell MD Trustee 1.00 55.00 X 0 3239502 125802 Laurie Glimcher MD Trustee 1.00 50.00 X 0 2000525 338932 Gary Fleisher MD Trustee 1.00 1.00 X 0 0 0 Stephen Karp Trustee 1.00 5.00 X 0 0 0 AJ Janower Trustee 1.00 1.00 X 0 0 0 Karen Linde Packman Trustee 1.00 1.00 X 0 0 0 Robert Smith Trustee 1.00 1.00 X 0 0 0 Beth Terrana Trustee 1.00 1.00 X 0 0 0 Doug Vanderslice Treasurer 1.00 55.00 X 0 1981768 75202 Scott Armstrong MD President 1.00 50.00 X 0 801450 73627 Lisa Diller MD Chief Medical Officer 1.00 50.00 X 0 525188 51520 Krietta Bowens Jones Clerk 1.00 50.00 X 0 263189 56092 Sandra Fenwick Former Trustee 0.00 0.00 X 0 958796 0 0 9770418 721175 0 1 1 0 0 0 0 0 0 X 296404 296404 296404 296404 0 0 0 0 0 0 X 0 0 0 0 X -296404 296404 X X 0 0 0 X X 2 Children's Hospital Corporation 042774441 3 1 148202 0 Dana-Farber Cancer Institute Inc 042263040 7 1 148202 0 2 296404 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 Kevin Churchwell MD Trustee 0 1548242 0 1160000 0 531260 0 24400 0 101402 0 3365304 0 0 Laurie Glimcher MD Trustee 0 1365076 0 487080 0 148369 0 321693 0 17239 0 2339457 0 0 Doug Vanderslice Treasurer 0 885183 0 754720 0 341865 0 27450 0 47752 0 2056970 0 0 Sandra Fenwick Former Trustee 0 0 0 0 0 958796 0 0 0 0 0 958796 0 958796 Scott Armstrong MD President 0 611194 0 109583 0 80673 0 42975 0 30652 0 875077 0 0 Lisa Diller MD Chief Medical Officer 0 422752 0 77951 0 24485 0 42975 0 8545 0 576708 0 0 Krietta Bowens Jones Clerk 0 262544 0 0 0 645 0 23890 0 32202 0 319281 0 0 Part I, Line 4b Children's Hospital Corporation and Dana-Farber Cancer Institute, related organizations, made contributions to the supplemental non-qualified retirement plan for the individuals listed below. Contribution amounts are generally based on a percentage of compensation. Participants of the supplemental executive retirement plan are fully vested. All payments with respect to a participant's separation from service will be made in a single sum following the separation from service unless participant has elected to receive the accrued interest portion of his or her account in three annual installments. Contributions were for Children's Hospital Corporation or Dana-Farber Cancer Institute employee benefits and not for Dana-Farber/Children's Hospital Cancer Care, Inc. Trustee or Officer of the Board services and/or responsibilities. During calendar year 2022, Children's Hospital Corporation made contributions to the supplemental non-qualified reitrement plan for the individuals below: Kevin Churchwell, MD received a contribution of $456,800 Laurie Glimcher, MD received a contribution of $133,537 Douglas Vanderslice received a contribution of $242,524 Scott Armstrong, MD received a contribution of $39,116 Lisa Diller, MD received a contribution of $15,440 During calendar year 2022, the following individual received supplemental executive retirement plan distributions from Children's Hospital Corporation: Sandra Fenwick received a distribution of $958,796 Form 990, Part VI, Section A, line 6 The members of the Corporation are Children's Hospital Corporation and Dana-Farber Cancer Institute, Inc., each acting through its Board of Trustees. Form 990, Part VI, Section A, line 7a Children's Hospital Corporation and Dana-Farber Cancer Institute, Inc. are members of the organization. Each member appoints half the Trustees. Form 990, Part VI, Section A, line 7b Prior to voting on any of the matters described in paragraphs (a) through (k) below, each Trustee entitled to vote shall consult with the designated officer of the member who appointed him or her. Dana-Farber Cancer Institute, Inc.'s designated officer is its president, and The Children's Hospital Corporation's designated officer is its chief operating officer. The Trustees appointed by a member may delegate to one or more of their number the responsibility for consulting with the designated officer of the member, so long as the substance of the designated officer's views on the matter in question are communicated to the other Trustees prior to the vote. Either prior to or after any such vote, each designated officer of a member may waive his or her right to be consulted on the matter in question. The affirmative vote of at least two-thirds of the Trustees entitled to vote shall be required for: (a) capital and operating budgets, and substantial unbudgeted expenditures; (b) the election and removal of officers listed; (c) fundraising and marketing programs; (d) merger, consolidation, joint venture or affiliation; (e) sale, lease, exchange, gift or other disposition of substantial assets or operations; (f) amendment to the Charter or Bylaws; (g) engagement of accountants, consultants or lawyers; (h) lending or borrowing funds, or guaranteeing the obligation of any person or entity to repay a loan; (i) granting a security interest in any asset of the organization; (j) creation of any subsidiary; and (k) purchase or lease of real estate, or substantial tangible personal property. Form 990, Part VI, Section B, line 11b The Form 990 tax return was prepared by the Children's Hospital staff and reviewed by management, along with the outside accounting firm of Ernst & Young. Form 990, Part VI, Section B Policies, Questions 12, 13 & 14 Dana-Farber / Children's Hospital Cancer Care, Inc. is a collaboration of two separate 501(c)(3) organizations - Dana-Farber Cancer Institute, Inc. and Children's Hospital Corporation. The organization does not have its own separate policy. Each entity follows their own conflict of interest, whistle blower and document retention/destruction policies. Thus, the organization is subject to the policies for both Dana-Farber Cancer Institute, Inc. and Children's Hospital Corporation. Form 990, Part VI, Section B, line 15 Dana-Farber / Children's Hospital Cancer Care, Inc. does not have any employees. The salary and benefits that are recorded on this tax return as an expense to Dana-Farber / Children's Hospital Cancer Care, Inc. are expenses to this entity for tax purposes, but the salaries are paid out of the individual's respective institutions for which they are employed. Thus Children's Hospital Corporation employees are paid by Children's Hospital Corporation and Dana-Farber Cancer Institute, Inc. employees are paid by Dana-Farber Cancer Institute, Inc. Form 990, Part VI, Section C, line 19 The organization does not have its own separate conflict of interest policy nor compliance manual. Each entity follows their own conflict of interest policy and compliance manual. Children's Hospital Corporation posts its Code of Conduct (which incorporates the Conflict of Interest Policy) and its Compliance Manual (which includes a summary of the Conflict of Interest Policy) on its external website and these are also available from the Compliance Office or the Office of General Counsel. Dana-Farber Cancer Institute,Inc. posts its Code of Conduct (which incorporates the Conflict of Interest Policy) and its Compliance Manual (which includes a summary of the Conflict of Interest Policy) on its external website and these are also available from the Human Resources Department, Compliance Office or the Office of General Counsel. Governing documents are not posted publicly but are available from the organization upon request and are also filed with the Massachusetts Secretary of State, where they are available to the public. Financial statements available upon request. Form 990, Part VII, Section A The individuals, who have compensation from related organizations, listed in Column E, spend the remainder of their full time hours working for Children's Medical Center and its other affiliates or for Dana-Farber Cancer Institute, Inc. Form 990, Part IX, line 11g Marketing expenses: Program service expenses 296,404. Management and general expenses 0. Fundraising expenses 0. Total expenses 296,404. Form 990, Part XI, line 9: Transfer of expenses paid by Children's Hospital & Dana-Farber Cancer Inst. 296,404. Form 990, Part XII, Financial Statements & Reporting, Question 2a & 2b Both members, Children's Hospital Corporation and Dana-Farber Cancer Institute, Inc. have audited financial statements. Further this organization does not meet Massachusetts' threshold for requiring a review or audit of the financial statements. Children's Hospital Corporation 300 Longwood Avenue Boston MA 02115 042774441 Pediatric healthcare, education and research hospital MA 501(c)(3) 3 - Hospital Children's Medical Center Corporation 0 Dana-Farber Cancer Institute Inc 450 Brookline Avenue BP418 Boston MA 02215 042263040 Cancer care research MA 501(c)(3) 7 - 170b1Avi N/A 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0